Insights On Pharma Logistics
-
Validation Of Integrated Cryogenic Systems For Cell Therapy Manufacturing
4/13/2021
Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.
-
Cell Therapy Logistics: Exploring The Last 100m
4/13/2021
If advanced therapies are to be scaled, their management at hospital sites must be scalable. How can we remove complexity — making life easier for couriers, manufacturers, and hospitals — and create a seamless supply chain?
-
Achieving A Flexible, Integrated And Sustainable Cryogenic Cold Chain Ecosystem
4/13/2021
During this discussion, panelists examine the cell and gene therapy solutions that have been designed to overcome challenges in the cryogenic cold chain ecosystem.
-
Digitally Connected, Liquid Nitrogen-Free Cryogenic Cold Chain
4/12/2021
A cryogenic cold chain starts with cryopreservation. Achieve consistent results without liquid nitrogen, scale effectively and efficiently, and get traceable digital records.
-
Liquid Nitrogen-Free Cryopreservation For Sustainability
4/5/2021
Discover the environmental implications of using liquid nitrogen for cell freezing, along with carbon emissions during the manufacture, transportation, and operation of LN2-free controlled-rate freezers.
-
The Science Of Cell Therapy Thawing
4/5/2021
A summary of the science of thawing following conventional slow freezing methods, the physical and biological implications of key metrics and components, and key studies from scientific literature.
-
Need For Speed: The Key To Successful Multi-Market Product Launches
3/29/2021
Launching a new drug in the European marketplace presents unique challenges. Numerous official working languages, complex independent regulatory requirements with an overarching framework, and the intricacy and scale of distribution are all characteristics of an EU launch. Jumping these hurdles is a given, but it’s the speed that makes the difference.
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
3/29/2021
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Managing Complex Global Drug Distribution And Expiry
1/12/2021
A global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced.
-
Enabling Fast, Appropriate Drug Product Supply For Phase 1 Trials
10/30/2020
Without the ability to move smoothly from lab concept to manufacture to delivery of GMP clinical supplies to patients, critical milestones could be missed, delaying funding commitments from investors.